Innate Pharma S.A (IPHA)

Trade IPHA now with
3/13/2023 2:20:56 AM Innate Pharma Says Does Not See Any Impact To Liquidity Position Or Ongoing Operations On Silicon Valley Bank Exposure
1/16/2023 1:14:35 AM Innate Pharma Publishes Preclinical Data With Trifunctional NK Cell Engager In AML In Nature Biotechnology
12/19/2022 1:03:32 AM Sanofi, Innate Pharma Expand Collaboration For Natural Killer Cell Therapeutics In Oncology
11/14/2022 1:04:47 AM Innate Pharma 9-month Revenues EUR 44.3 Mln Vs EUR 10.3 Mln Last Year
9/15/2022 1:07:13 AM Innate Pharma H1 EPS EUR 0.08 Vs Loss EUR 0.30 Last Year
8/1/2022 1:07:02 AM Innate Says AstraZeneca To Discontinue Phase 3 Study Of Monalizumab Combination In Metastatic Squamous Cell Carcinoma
7/21/2022 1:21:29 AM Innate Pharma Says Sanofi Made Decision To Progress IPH6401/SAR'514 Into IND-enabling Studies
6/3/2022 1:07:42 AM Innate Pharma To Advance Into Phase 2 Clinical Trial In Lung Cancer
5/10/2022 1:06:16 AM Innate Pharma Q1 Revenues EUR 2.6 Mln Vs EUR 4.5 Mln Last Year
4/8/2022 1:05:51 AM Innate Pharma To Hold AGM Of Shareholders On May 20, 2022
3/24/2022 2:06:59 AM Innate Pharma FY Loss EUR 52.8 Mln Vs. Net Loss EUR 64.0 Mln Prior Year
1/5/2022 1:04:12 AM Innate Pharma Obtains EUR 28.7 Mln In Non-dilutive financing In Form Of Two Loans From Socit Gnrale And BNP Paribas